Rozov Yadin

Director Yadin Rozov sells 4,726 shares at blended avg $228.06 for $1.1M; retains 75.2K shares post-sale.

Yadin Rozov, a Director of Dave Inc., executed 5 separate sales totaling 4,726 shares for $1,077,816.16 on 2025-09-12, reducing his holdings by 5.9% to 75,197 shares. The sales occurred at prices ranging from $225.21 to $229.75, with a blended average of $228.06—close to the current price of $229.42. Across his cross-ticker track record, prior sells show an average 90-day return of -10.6% with a 33.33% well-timed rate; however, his 5 prior trades at DAVE (all sales on 2025-09-04) have not yet reached measurable outcomes at the 90-day horizon. The stock is currently -18.6% from its 52-week high of $281.79 and has gained 14.4% over the past 30 days, suggesting a recovery phase from earlier weakness. The company's fundamentals show strong growth with annual revenue growth of +34.0% and a P/E of 49.66, indicating a premium valuation despite solid profitability (net income $9.0M on $131.8M revenue). The sale represents a meaningful but not extraordinary reduction in his position, occurring during a period of recent stock momentum.

Director Rozov Yadin sold 14,660 shares on 2025-09-04 for $2,925,321.75 (avg $199.54), reducing stake by 15.5%

Rozov Yadin executed nine separate sales totaling 14,660 shares for $2,925,321.75 on 2025-09-04, with prices ranging from $195.79 to $203.99—a blended average of $199.54. This represents a 15.5% reduction in his holdings at DAVE, from 94,583 shares to 79,923 shares. At a current price of $194.65, the stock trades 30.9% below its 52-week high of $281.79 and has declined 12.1% over the past 90 days. Reviewing his prior four trades at DAVE (two sells in June 2025, two buys in late 2023 and early 2024), 2 of 4 were well-timed at the 90-day mark, showing mixed predictive value for current market direction. The company reports quarterly revenue of $131,757,000 and net income of $9,040,000 with 34.0% annual revenue growth, though the stock commands a P/E of 42.13, suggesting elevated valuation relative to earnings.

Director Yadin Rozov sold 5,500 shares for $1,138,147.00 at blended $206.94; retains 95,678 shares.

Rozov executed 2 separate sales totaling 5,500 shares for $1,138,147.00 on 2025-06-04, reducing his position by 5.4%. His cross-ticker track record shows 1 prior sell that was well-timed (100% of prior sells were well-timed as the stock declined afterward), while at DAVE specifically his 2 prior buys both showed strong positive 90-day returns (+1.2% and +256.8%). The stock is currently at $209.17, near its 52-week high of $217.16, and has gained 97.5% in the past 30 days and 150.9% in the past 90 days on strong fundamentals (revenue growth +34.0%, $108.0M quarterly revenue, $28.8M net income). His prior transaction timing at this ticker has been sound, and this sale occurs at elevated price levels following a sustained rally.

Director Rozov Yadin purchased 110.0K shares of CORZ at $10.87 on 2025-05-28 (total value $1.2M), expanding stake 30.1% to 475.7K shares.

Director Rozov Yadin executed a substantial open-market purchase of 110,000 shares valued at $1,195,370.00, increasing his holdings by 30.1% to 475,687 shares. His prior transaction history at this ticker shows strong 90-day outcomes: his March 2024 buy returned +220.4% over 90 days, and his November 2024 sell was well-timed (down 34.6% 90-day post-sale), indicating consistent pattern recognition over a two-trade span. However, the current price of $10.69 sits -41.4% from the 52-week high and -1.7% below the purchase price, placing this buy 30 days into a +29.0% monthly rebound from lower levels. The company's full-year net income was negative, yet the latest quarterly net income shows $580.7M—a critical discrepancy that warrants clarity on one-time items, restructuring charges, or accounting methodology before assessing whether this purchase reflects genuine operational improvement or a temporary swing in reported earnings.

Director Rozov Yadin sold 105.0K shares of CORZ at $18.11; remaining 345.2K shares. Stock now at $18.23 after +34.8% 30-day rally.

Rozov sold 105,000 shares (23.3% of prior holdings) at $18.11 during a period of strong momentum: the stock has risen +34.8% over 30 days and +69.4% over 90 days, currently trading at its 52-week high of $18.23. The timing is noteworthy given his cross-ticker track record shows 100% success rate on 3 prior buys with average 90-day returns of +159.5%, yet at Core Scientific specifically, his prior March 2024 buy resulted in a +220.4% gain over 90 days—a substantially more volatile outcome than his cross-ticker average. The company remains unprofitable (net income $-455.3M in the latest full year) with shrinking revenue (-21.5% annual growth), creating a disconnect between the stock's valuation momentum and fundamental deterioration. The sale occurred just 20 months after his prior purchase at this ticker, suggesting a reassessment of holdings after significant gains.